Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 12/05 05:27:37 pm
76.77 USD   +1.68%
12/02 VERTEX PHARMACE : VRTX) Files An 8-K Departure of Directors or Certa..
11/29 NASDAQ 100 MOVE : Bmrn, nflx
11/11 NASDAQ 100 MOVE : Alxn, nvda
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2016 11/30/2016 12/01/2016 12/02/2016 12/05/2016 Date
85.65(c) 81.61(c) 77.82(c) 75.5(c) 76.77 Last
1 745 516 2 292 728 2 662 560 4 580 479 790 997 Volume
-1.44% -4.72% -4.64% -2.98% +1.68% Change
More quotes
Financials ($)
Sales 2016 1 693 M
EBIT 2016 182 M
Net income 2016 -134 M
Finance 2016 185 M
Yield 2016 -
Sales 2017 2 225 M
EBIT 2017 621 M
Net income 2017 275 M
Finance 2017 216 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 74,98
EV / Sales2016 10,9x
EV / Sales2017 8,32x
Capitalization 18 727 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
12/02 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K Departure of Directors..
12/02 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
11/29 NASDAQ 100 MOVERS : Bmrn, nflx
11/17 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
11/14 VERTEX PHARMACEUTICALS INCORPORATED : Assigned Patent
11/11 NASDAQ 100 MOVERS : Alxn, nvda
11/10 VERTEX PHARMACEUTICALS INCORPORATED : to Present at the Credit Suisse Healthcare..
11/09 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Pops 11.92% for November 09
11/07 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
11/03 VERTEX PHARMACEUTICALS INCORPORATED : Announces Planned Initiation of Phase 2 St..
More news
Sector news : Bio Therapeutic Drugs
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
12/02 Vertex promotes two execs
11/30 Cystic Fibrosis Spotlight Turns To Galapagos
11/29 Barclays softens views on five biopharma firms
11/29 Galapagos launches early-stage study of corrector drug for cystic fibrosis, e..
11/28 Nivalis' cystic fibrosis candidate cavosonstat flunks mid-stage study; shares..
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 102 $
Spread / Average Target 35%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith Chief Financial Officer & Executive Vice President
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-38.15%18 727
AMGEN, INC.-11.29%107 132
GILEAD SCIENCES, INC.-28.02%95 410
CELGENE CORPORATION-1.78%91 187
REGENERON PHARMACEUTIC..-31.34%39 310
ACTELION LTD40.40%21 739
More Results